Glatiramer Acetate Modifies the Immune Profiles of Monocyte-Derived Dendritic Cells In Vitro Without Affecting Their Generation
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26073013 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Jelena Skuljec und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology and Center for Translational Neuro- and Behavioral Sciences (C-TNBS), University Medicine Essen, University Duisburg-Essen, 4…. Hauptthemen laut MEDLINE: Glatiramer Acetate, Dendritic Cells, Monocytes. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Teva Pharmaceuticals (Israel), Teva Pharmaceutical Industries Ltd., University of Duisburg-Essen, Germany.
Abstract (Originalsprache)
Glatiramer acetate (GA) is the first-line therapy for relapsing-remitting multiple sclerosis (MS) and is increasingly demonstrating promising therapeutic benefits in a range of other conditions. Despite its extensive use, the precise pharmacological mechanism of GA remains unclear. In addition to T and B cells, dendritic cells (DCs) and monocytes play significant roles in the neuroinflammation associated with MS, positioning them as potential initial targets for GA. Here, we investigated GA’s influence on the differentiation of human monocytes from healthy donors into monocyte-derived dendritic cells (moDCs) and assessed their activation status. Our results indicate that GA treatment does not hinder the differentiation of monocytes into moDCs or macrophages. Notably, we observed a significant increase in the expression of molecules required for antigen recognition, presentation, and co-stimulation in GA-treated moDCs. Conversely, there was a significant downregulation of CD1a, which is crucial for activating auto-aggressive T cells that respond to the lipid components of myelin. Furthermore, GA treatment resulted in an increased expression of CD68 on both CD14+CD16+ and CD14+CD16− monocyte subsets. These in vitro findings suggest that GA treatment does not impede the generation of moDCs under inflammatory conditions; however, it may modify their functional characteristics in potentially beneficial ways. This provides a basis for future clinical studies in MS patients to elucidate its precise mode of action.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology and Center for Translational Neuro- and Behavioral Sciences (C-TNBS), University Medicine Essen, University Duisburg-Essen, 45147 Essen, Germany.
- Department of Neurology, Hannover Medical School, 30625 Hannover, Germany.
- Institute for Experimental Immunology and Imaging, University Medicine Essen, University of Duisburg-Essen, 45147 Essen, Germany.
- Department of Neurobiology, Institute for Biological Research "Sinisa Stankovic"-National Institute of Republic of Serbia, University of Belgrade, 11000 Belgrade, Serbia.
ORCID-Profile: Jelena Skuljec, Maryam Sardari, Marija M Janjic, Christoph Kleinschnitz
Förderung
- Teva Pharmaceuticals (Israel)
- Teva Pharmaceutical Industries Ltd.
- University of Duisburg-Essen, Germany
Zitieren
APA
Skuljec, J., Sardari, M., Su, C., Müller-Dahlke, J., Singh, V., Janjic, M. M., Kleinschnitz, C., & Pul, R. (2025). Glatiramer Acetate Modifies the Immune Profiles of Monocyte-Derived Dendritic Cells In Vitro Without Affecting Their Generation. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26073013
Vancouver
Skuljec J, Sardari M, Su C, Müller-Dahlke J, Singh V, Janjic MM, et al. Glatiramer Acetate Modifies the Immune Profiles of Monocyte-Derived Dendritic Cells In Vitro Without Affecting Their Generation. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26073013
BibTeX
@article{Skuljec2025,
author = {Skuljec, Jelena and Sardari, Maryam and Su, Chuanxin and Müller-Dahlke, Julia and Singh, Vikramjeet and Janjic, Marija M and Kleinschnitz, Christoph and Pul, Refik},
title = {Glatiramer Acetate Modifies the Immune Profiles of Monocyte-Derived Dendritic Cells In Vitro Without Affecting Their Generation},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26073013}
}
EUVIMED